Coronavirus Update for Tuesday, November 10
The following is the latest COVID-19 information from the federal government as of 2:30 p.m. on Tuesday, November 10. Food and Drug Administration The FDA has issued emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. In issuing this EUA, the FDA noted that “While the safety and effectiveness of this investigational therapy continues to be evaluated, bamlanivimab was shown in clinical trials to reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression within 28 days after treatment when compared to [...]
